Glyburide

Product NDC: 68071-2189
11-digit product format: 680712189
Labeler code: 68071
Product ID: 68071-2189_4b6b2ce1-e34a-3921-e054-00144ff8d46c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glyburide
Dosage form: TABLET
Route: ORAL
Labeler: NuCare Pharmaceuticals, Inc.
Application: ANDA074388
Marketing category: ANDA
Marketing start: 1995-08-30
Marketing end: 0000-00-00
Substance: GLYBURIDE
Active strength: 3 mg/1
Pharmacologic classes: Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	68071-2189		I	Inactivated by FDA	2026-08-17
excluded package	package	68071-2189	68071-2189-3	I	Inactivated by FDA	2026-08-17
excluded package	package	68071-2189	68071-2189-6	I	Inactivated by FDA	2026-08-17
excluded package	package	68071-2189	68071-2189-8	I	Inactivated by FDA	2026-08-17
excluded package	package	68071-2189	68071-2189-9	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68071-2189-9	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68071-2189-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68071-2189-6	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68071-2189-8	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68071-2189-9	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68071-2189-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68071-2189-6	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68071-2189-8	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68071-2189-9	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68071-2189-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68071-2189-6	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68071-2189-8	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68071-2189-9	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68071-2189-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68071-2189-6	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68071-2189-8	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68071-2189-9	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68071-2189-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68071-2189-6	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68071-2189-8	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68071-2189-9	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68071-2189-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68071-2189-6	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68071-2189-8	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2189-6	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2189-8	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2189-9	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2189-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2189-6	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2189-8	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2189-9	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2189-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2189-6	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2189-8	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2189-9	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2189-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074388-001	GLYBURIDE	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29
A074388-002	GLYBURIDE	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29
A074388-003	GLYBURIDE	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A074388-001	AB1
A074388-002	AB1
A074388-003	AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074388-002	GLYBURIDE	2.5MG	TABLET / ORAL	AB1		1995-08-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074388-003	GLYBURIDE	5MG	TABLET / ORAL	AB1	RS	1995-08-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074388-001	GLYBURIDE	1.25MG	TABLET / ORAL	AB1		1995-08-29	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A074388-001	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A074388-002	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A074388-003	AB1	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A074388-001	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074388-002	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074388-003	AB1	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074388-001	AB1	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074388-002	AB1	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074388-003	AB1	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074388-001	AB1	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074388-002	AB1	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074388-003	AB1	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074388-001	AB1	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074388-002	AB1	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074388-003	AB1	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074388-001	AB1	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074388-002	AB1	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074388-003	AB1	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074388-001	AB1	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074388-002	AB1	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074388-003	AB1	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074388-001	AB1	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074388-002	AB1	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074388-003	AB1	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074388-001	AB1	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074388-002	AB1	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074388-003	AB1	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074388-001	AB1	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074388-002	AB1	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074388-003	AB1	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074388-001	AB1	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074388-002	AB1	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074388-003	AB1	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074388-001	AB1	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074388-002	AB1	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074388-003	AB1	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074388-001	AB1	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074388-002	AB1	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074388-003	AB1	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074388-001	AB1	1	`1e350fbaab3a…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bea938a6-c880-985b-d27b-b59b0d8b5a77	Product name	3	20170626
0600b0d3-c32a-40bb-8d87-3a2934cd8f2f	Product name	1	20170616
64b2b6e2-1c04-cf4a-db4c-078ed10e1dd6	Product name	2	20160609
5a2baaae-1290-c05e-207f-b1367e9eb46a	Product name	2	20151005
b044018d-bcdc-e68d-63da-1ad6886aea64	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
68071-2189-3	GLYBURIDE TABLETS USP 1.25, 2.5, and 5 mg 8342 8343 8344 Rx only
68071-2189-6	GLYBURIDE TABLETS USP 1.25, 2.5, and 5 mg 8342 8343 8344 Rx only
68071-2189-8	GLYBURIDE TABLETS USP 1.25, 2.5, and 5 mg 8342 8343 8344 Rx only
68071-2189-9	GLYBURIDE TABLETS USP 1.25, 2.5, and 5 mg 8342 8343 8344 Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68071-2189-3	Glyburide	30 in 1 BOTTLE	TABLET	30	4
68071-2189-6	Glyburide	60 in 1 BOTTLE	TABLET	60	4
68071-2189-8	Glyburide	180 in 1 BOTTLE	TABLET	180	4
68071-2189-9	Glyburide	90 in 1 BOTTLE	TABLET	90	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-2189	GLYBURIDE TABLET [NUCARE PHARMACEUTICALS, INC.]	4	Legacy NDC, 4 package rows	20230621_4b6b2ce1-e349-3921-e054-00144ff8d46c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glyburide	GLYBURIDE	Preferred Pharmaceuticals Inc.	bc8df889-25e0-49a0-bbec-a3dfae8bbb8a	2026-01-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	Coupler LLC	4573af7f-3c71-e323-e063-6394a90aa9eb	2025-12-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	Proficient Rx LP	6f65131c-90df-45ab-95fb-c36f411c6fbe	2025-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	NuCare Pharmaceuticals, Inc.	25516c2a-f1b5-9ee4-e063-6394a90ab46b	2024-10-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	NuCare Pharmaceuticals, Inc.	21786ac0-da3c-16cb-e063-6394a90a4596	2024-09-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	A-S Medication Solutions	922d1080-52c6-41e4-a310-533d8ca18594	2023-08-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	Proficient Rx LP	ec45f0d8-cab8-4822-895b-17bb443a4f98	2019-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388
Glyburide	GLYBURIDE	Teva Pharmaceuticals USA, Inc.	a56f100f-0f42-4188-81ab-04644b824040	2015-05-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074388 application number: ANDA074388

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
SX6K58TVWC	GLYBURIDE	10238-21-8	GLYBURIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310534	glyBURIDE 2.5 MG Oral Tablet	PSN	4b6b2ce1-e349-3921-e054-00144ff8d46c	4
310534	glyburide 2.5 MG Oral Tablet	SCD	4b6b2ce1-e349-3921-e054-00144ff8d46c	4
310534	glibenclamide 2.5 MG Oral Tablet	SY	4b6b2ce1-e349-3921-e054-00144ff8d46c	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68071-2189-3	68071218903	30 in 1 BOTTLE	Historical
68071-2189-6	68071218906	60 in 1 BOTTLE	Historical
68071-2189-8	68071218908	180 in 1 BOTTLE	Historical
68071-2189-9	68071218909	90 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GLYBURIDE TABLETS USP 1.25, 2.5, and 5 mg 8342 8343 8344 Rx only	NuCare Pharmaceuticals, Inc.	2023-06-20	HUMAN PRESCRIPTION DRUG LABEL	4